烯丙吗啡:修订间差异
删除的内容 添加的内容
←建立内容为“{{Drugbox | Verifiedfields = verified | Watchedfields = verified | verifiedrevid = 402503832 | IUPAC_name = 17-allyl-7,8-didehydro-4,5α-epoxymorphinan-3,6α-diol | image = Nalorphine.svg | width = 225px <!--Clinical data--> | tradename = Lethidrone, Nalline | Drugs.com = {{drugs.com|international|nalorphine}} | pregnancy_AU = <!-- A / B1 / B2 / B3 / C / D / X --> | pregnancy_US = <!-- A / B / C / D / X --> | pregnancy_category = | legal_AU =…”的新页面 |
无编辑摘要 |
||
第58行: | 第58行: | ||
| StdInChIKey = UIQMVEYFGZJHCZ-SSTWWWIQSA-N |
| StdInChIKey = UIQMVEYFGZJHCZ-SSTWWWIQSA-N |
||
}} |
}} |
||
<ref name="Glatt2012">{{cite book| vauthors = Glatt M |title=The Dependence Phenomenon|url=https://books.google.com/books?id=rN7dBgAAQBAJ&pg=PT121|date=6 December 2012|publisher=Springer Science & Business Media|isbn=978-94-011-7457-2|pages=121–}}</ref>。 |
|||
==参考文献== |
|||
{{reflist}} |
|||
==外部链接== |
2024年2月13日 (二) 05:30的版本
臨床資料 | |
---|---|
商品名 | Lethidrone, Nalline |
其他名稱 | N-Allylnormorphine |
AHFS/Drugs.com | 国际药品名称 |
ATC碼 | |
法律規範狀態 | |
法律規範 |
|
识别信息 | |
| |
CAS号 | 62-67-9 |
PubChem CID | |
IUPHAR/BPS | |
DrugBank | |
ChemSpider | |
UNII | |
KEGG | |
ChEBI | |
ChEMBL | |
CompTox Dashboard (EPA) | |
ECHA InfoCard | 100.000.497 |
化学信息 | |
化学式 | C19H21NO3 |
摩尔质量 | 311.38 g·mol−1 |
3D模型(JSmol) | |
| |
|
[2]。
参考文献
- ^ Anvisa. RDC Nº 784 - Listas de Substâncias Entorpecentes, Psicotrópicas, Precursoras e Outras sob Controle Especial [Collegiate Board Resolution No. 784 - Lists of Narcotic, Psychotropic, Precursor, and Other Substances under Special Control]. Diário Oficial da União. 2023-03-31 (2023-04-04) [2023-08-03]. (原始内容存档于2023-08-03) (巴西葡萄牙语).
- ^ Glatt M. The Dependence Phenomenon. Springer Science & Business Media. 6 December 2012: 121–. ISBN 978-94-011-7457-2.